| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.089 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |